These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 25809736)
21. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside. Sachdeva MM; Eliott D Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126 [TBL] [Abstract][Full Text] [Related]
22. A strategy to ensure safety of stem cell-derived retinal pigment epithelium cells. Choudhary P; Whiting PJ Stem Cell Res Ther; 2016 Sep; 7(1):127. PubMed ID: 27590276 [TBL] [Abstract][Full Text] [Related]
23. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration. Du H; Lim SL; Grob S; Zhang K Semin Ophthalmol; 2011 May; 26(3):216-24. PubMed ID: 21609235 [TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Parameswaran S; Balasubramanian S; Babai N; Qiu F; Eudy JD; Thoreson WB; Ahmad I Stem Cells; 2010 Apr; 28(4):695-703. PubMed ID: 20166150 [TBL] [Abstract][Full Text] [Related]
29. A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Maruotti J; Wahlin K; Gorrell D; Bhutto I; Lutty G; Zack DJ Stem Cells Transl Med; 2013 May; 2(5):341-54. PubMed ID: 23585288 [TBL] [Abstract][Full Text] [Related]
30. miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age-related macular degeneration. Murad N; Kokkinaki M; Gunawardena N; Gunawan MS; Hathout Y; Janczura KJ; Theos AC; Golestaneh N FEBS J; 2014 Dec; 281(23):5251-64. PubMed ID: 25251993 [TBL] [Abstract][Full Text] [Related]